Background: This study explores the effect of age at the time of parental cancer diagnosis or death on psychological distress and cancer risk perception in individuals undergoing genetic testing for a specific cancer susceptibility.
introduction
Genetic testing for a cancer predisposition has become a usual component of clinical practice over the last years. The impact of genetic testing on mental health has been well documented. Despite quite favourable outcomes on the group level, about 10-20% of individuals undergoing genetic testing for a BRCA1/2 mutation (high risk of breast/ovarian cancer) or an HNPCC associated mutation (high risk of colon/endometrial cancer) are highly distressed [1] [2] [3] [4] [5] and about 20-85% continue to have incorrect risk perceptions after genetic counselling [6] . Interestingly, mutation carrier status has only rarely been found to be related to distress levels more than one month after result disclosure [7] . Other individual characteristics may contribute more to psychological distress and cancer risk perceptions than mutation carrier status. To date there is only limited knowledge about these specific individual characteristics [8] .
It has been suggested that risk perception and distress levels are influenced by experiences with cancer in the family [9, 10] . Indeed, studies assessing the psychological impact of parental cancer experiences have found a greater feeling of vulnerability to cancer [11] and more anxiety [12] in women with mothers affected by breast cancer. Women having lost their mothers to cancer reported more cancer specific distress [13, 14] . The impact of parental loss would depend more precisely on the developmentally determined attachment to the affected parent. Loss of a parent in childhood has been shown to result in a more insecure attachment style [15] , more complicated grief to subsequent losses [16] and an increased risk to develop depressive disorders [17, 18] in adulthood.
Two papers have explored the impact of parental cancer and loss due to cancer in childhood on adult individuals. Adult women who were teenagers at the time of their mothers breast cancer diagnosis felt more uncomfortable about involvement in their mothers' illness as compared to women who were adults at the time of their mothers' breast cancer [19] . Adult women at familial risk of breast cancer who were teenagers when they lost their mothers to cancer perceived a higher risk of developing breast cancer, compared with women with an affected mother at another age [20] .
From a developmental point of view, several factors could explain the vulnerability of children and adolescents after the confrontation with parental cancer and loss due to cancer. Young children may be vulnerable because they are still dependent on the care of their parents and may have less affective and cognitive resources to cope with stressful life events [21] . Adolescents may be vulnerable because the illness or loss of a parent may interfere with the developmental task to change the parent-child relationship in order to reach independence [22, 23] . Girls having a mother affected with breast cancer at the time they are developing breasts themselves, may become more anxious and ambivalent towards their own breasts [19] .
To date, no study has documented the impact of age at the time of parental cancer and loss on individuals from hereditary cancer families undergoing genetic testing. The objective of the present study was to explore the impact of parental cancer and loss at several developmental phases on psychological distress and cancer risk perception during the genetic testing process. Developmental phases focused upon were childhood and adolescence and specifically the time of breast development (puberty) in women with breast cancer affected mothers.
methods participants
Applicants for genetic susceptibility testing for a known familial pathogenic gene mutation in BRCA1/2 or a in a HNPCC related gene (MSH2, MLH1 or MSH6) aged 18 and over were asked to participate in a psychological study. Applicants were eligible for the study if they had a relative with an identified gene mutation, irrespective of cancer status and of the decision to proceed with genetic testing. We excluded individuals with insufficient proficiency in Dutch and males from BRCA1/2 families because they are not at high risk of developing cancer. Accrual took place from January 2003 to October 2004 at the University Medical Centres of Rotterdam, Leiden and Groningen.
procedure Applicants for genetic testing for a known familial mutation received at least two counselling sessions. Blood sampling generally took place at the end of the first counselling session if the applicant proceeded with genetic testing. Six to 10 weeks after blood sampling the test result was disclosed in a counselling session. The three participating institutions adhered to the national guidelines on genetic counselling and therefore communicated the same cancer risks [24] .
The first questionnaire was received 1 week after the first counselling session. Participants willing to receive the genetic test result received a second and a third questionnaire one week and six months, respectively, after result disclosure. Participants who did not proceed with genetic testing received no second questionnaire, but filled in the third questionnaire 8 months after the first counselling session. The study was approved by the medical ethics committees of the participating institutions.
measures
At the first assessment, data were obtained on age, sex, having children, cancer status, pre-test genetic risk, cancer status of parents and age at the time of the parental cancer diagnosis or death.
We categorised participants according to three developmental phases [22] at the time of the parental cancer diagnosis or death due to cancer: children (participant was younger than 13 years), adolescents (between 13 and 20 years) and adults (older than 20 years).
In addition, we categorised participants having a mother affected with breast cancer according to the following developmental phases [22] at the time of mother's diagnosis: children (participant was younger than 10 years), puberty or the time of breast development (between 10 and 13 years) and adolescents/adults (14 years or older).
At each assessment, participants completed the Impact of Event Scale Revised [25, 26] measuring hereditary cancer related distress, the Cancer Worry Scale [27] and their feelings about their lifetime risk of developing cancer (risk perception) on a 7-point scale from not likely (1) to very likely (7) .
data analysis
The data were analysed using Statistical Package for Social Sciences (version 11.0) and PROC MIXED (SAS System, version 8.2). Demographic and clinical characteristics of the study sample were analysed using exact tests for categorical variables and T-tests for continuous variables.
In order to determine differences over time between several developmental phases of parental cancer occurrence, the method of random effects models (REM) was used for hereditary cancer related distress, cancer worry and risk perception as outcome variables. In this study, the method of estimation was REML (Residual Maximum Likelihood) and the error structure was defined as unstructured. For each outcome variable, we started with a model with the intercept, time and time squared in the random part, and time and time squared in the fixed part. To test whether a simpler random model was allowed, the difference between the -2 log likelihood goodness of fit between the reduced and the saturated model was evaluated. Releasing time squared from the random part resulted in a simpler model without losing substantial information. Subsequently, we entered the predictor variables (developmental phase of parental cancer occurrence) and confounding variables (sex, age, offspring, cancer syndrome, pre-test genetic risk, cancer status, genetic test result, time since experience) in the fixed part of the model. results study population 271 patients participated in the study. Non-participants (23%) and dropouts (3%) did not differ from participants with regard to age, sex, offspring, cancer syndrome, pre-test genetic risk and cancer status. Non-participants, however, more often refrained from genetic testing than participants (v 2 = 9.4; P < 0.01). Participants belonged to 96 different BRCA1/2 and 45 different HNPCC mutation families (Table 1) . Twenty-one patients were affected by cancer: nineteen had finished treatment 6 months to 28 years ago; two were diagnosed after having completed the second measurement and were excluded from the third measurement.
effect of parental cancer or loss to cancer in childhood, adolescence or adulthood Table 2 shows the number of participants with parental cancer experiences at several developmental phases. The courses of the outcome variables for participants having an affected parent at several developmental phases are displayed in Figure 1 . The analyses were controlled for age, sex, offspring, cancer status, hereditary cancer syndrome, genetic test result and time since parent's cancer diagnosis or death. Explained variances of the final models for cancer related distress, cancer worry and risk perception were 65.0%, 70.5% and 36.4%, respectively. The course of distress, worry and risk perception over the study period was not different for the four subgroups. Participants having an affected parent in childhood reported significantly more cancer related distress (t = 2.38; P < 0.05) a tendency towards more worry (t = 1.91; P = 0.06) and significantly higher perceived cancer risk (t = 2.13; P < 0.05) over the study period than the other three subgroups. Participants with an affected parent perceived the risk of developing cancer as higher over the study period than participants with no affected parent (t = ÿ2.13; P < 0.05). The above-described differences were also found in individuals having lost a parent at one of the three developmental phases, but without reaching statistical significance.
effect of a mother's breast cancer in puberty (age 10-13)
The analyses were controlled for age, sex, offspring, cancer status, hereditary cancer syndrome, genetic test result and time since parent's cancer diagnosis (Figure 2 ). Explained variances of the final models for cancer related distress, cancer worry and risk perception were 66.9%, 68.8% and 37.3%, respectively. Participants having a mother affected by breast cancer during puberty (n = 12) perceived their risk of developing breast cancer as higher (t = 2.21; P < 0.05) and tended to report more cancer worry (t = 1.93; P = 0.06) over the study period, than women with an affected mother after puberty (n = 60) or without an affected mother (n = 92). Women who had a mother affected by breast cancer before puberty (n = 11) reported the highest level of hereditary cancer related distress (t = 3.28; P < 0.01) and cancer worry (t = 2.12; P < 0.05).
discussion
This study demonstrates that the confrontation with parental cancer in childhood is a risk factor for psychological distress when coping with genetic testing for a cancer predisposition original article Annals of Oncology in adulthood. We found that those having an affected parent or having lost a parent to cancer before adolescence were psychologically most vulnerable. They reported the highest levels of hereditary cancer related distress, cancer worry and cancer risk perception several years later when going through the process of genetic testing for a hereditary cancer susceptibility. Interestingly, the courses of distress, worry and risk perception through time were similar in all groups. This might suggest that distress levels are continuously increased in individuals having an affected parent or having lost a parent to cancer before adolescence, also far before and after they opt for genetic testing. The finding of increased distress in individuals having an affected parent or having lost a parent to cancer before adolescence is, however, not in line with the study from Hopwood et al. [20] , who reported low levels of cancer worry in women at risk of breast cancer having lost their mothers before age ten years outside the setting of genetic testing. Because they did not control for relevant confounding variables, the reported low level of cancer worry may be due to other underlying factors like age at the time of genetic counselling. As expected, having a parent affected by cancer during adolescence resulted in a higher perceived risk of developing cancer, irrespective of risk and gene mutation status. Psychological distress was not more frequent in this group. These findings are in line with studies in grown up daughters of breast cancer patients outside the genetic testing setting [19, 20] . We also confirmed our expectation that women having a mother affected with breast cancer at the time of breast development (i.e. in puberty) perceived their risk of developing cancer as higher and were more distressed. But again, women 
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who were under age 10 at the time of their mothers' diagnosis reported the highest levels of distress over time.
Despite the vulnerability of adolescents due to the stress of adjusting family boundaries to their independence in a period of illness [28] , adolescents may be more apt in finding support from others outside the family, may have more mature coping mechanisms and may be better informed about the illness of the parent as compared to younger children [29] . This may enable the adolescent to cope with and work through the illness or loss experience, which can be of help several years later when confronted with increased cancer risks. Since younger children are more dependent on their parents, their fear of the loss of an important caregiver may be more threatening [21] . Furthermore, younger children may not have the cognitive and emotional abilities to fully understand and cope with the intense emotional and physical suffering from the parent. Parents may have informed younger children less completely about the illness [30] and may have avoided communicating about cancer more frequently in order to protect them [31, 32] . Younger children consequently might be less able to correctly integrate the experience into the autobiographical knowledge base. When these children have grown up, poorly integrated representations of the illness might influence the perceived meaning of the cancer risk.
Individuals with an affected parent felt more vulnerable to cancer than individuals without affected parents, irrespective of pre-test genetic risk. Moreover, participants with an affected parent continued to feel more at risk after result disclosure, irrespective of genetic risk status. It has been suggested that individuals develop an image of their future lives through identification with their parents [9, 21] . Identifications may be more prominent in young and adolescent children, resulting in a higher cancer risk perception in these groups.
To our knowledge, this is the first study to analyse the impact of parental cancer on individuals from identified gene mutation families undergoing genetic testing. Strengths of our study are the prospective study design, low drop out rate and method of statistical analyses. Furthermore we controlled for confounding variables and used psychologically meaningful age categories. Limitations were the small sample of individuals having lost a parent before adolescence and the lesser participation of individuals not opting for genetic testing. For the future, it is warranted to study a larger sample of children of parents with hereditary cancer, in order to validate and refine our results. Another unanswered question is if having a mother affected with cancer has a more profound impact than having an affected father on the long term.
We recommend that health care professionals pay attention to the psychological impact of experiences with parental cancer. Especially, monitoring the psychological resilience of those having witnessed parental cancer as a child is necessary in case of increased cancer risks.
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